Abstract
Increase in the intracellular levels of cyclic AMP (cAMP) is an essential event participating inthe inhibition of skeletal muscle protein degradation by catecholamines, after binding to beta 2-adrenoceptors. Two intracellular cAMP-dependent effectors seem to be involved in the antiproteolytic response of cAMP in the skeletal muscle: I) EPAC (Exchange protein directly activated by cAMP) th…